Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Combination Immune Checkpoint Blockade Strategies to Maximize Immune Response in Gynecological Cancers ; volume:20 ; number:12 ; day:13 ; month:11 ; year:2018 ; pages:1-11 ; date:12.2018
Current oncology reports ; 20, Heft 12 (13.11.2018), 1-11, 12.2018
- Urheber
-
Liu, Ying L.
Zamarin, Dmitriy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-018-0740-8
- URN
-
urn:nbn:de:101:1-2019020420423234511527
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liu, Ying L.
- Zamarin, Dmitriy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune checkpoint inhibitors in the treatment of virus-associated cancers
TOX: a potential new immune checkpoint in cancers by pancancer analysis
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
Neurosarcoidosis following Immune Checkpoint Inhibition
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
Radiation oncology of gynecological cancers
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis
Immune checkpoint inhibitors in the treatment of virus-associated cancers
TOX: a potential new immune checkpoint in cancers by pancancer analysis
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
Neurosarcoidosis following Immune Checkpoint Inhibition
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
Radiation oncology of gynecological cancers
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy
Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis
Immune checkpoint inhibitors in the treatment of virus-associated cancers
TOX: a potential new immune checkpoint in cancers by pancancer analysis
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
VISTA as a prospective immune checkpoint in gynecological malignant tumors: A review of the literature
Neurosarcoidosis following Immune Checkpoint Inhibition
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
Radiation oncology of gynecological cancers
Immune checkpoint receptors in regulating immune reactivity in rheumatic disease
Signal detection of immune thrombocytopenia associated with immune checkpoint inhibitors
Safety of sequential immune checkpoint inhibitors after prior immune therapy